MAY 12, 2021 9:00 AM PDT

Illuminating the COVID-19 Disease Profile Puzzle

WRITTEN BY: Caroline Wallace

Teams of science experts from numerous disciplines have been collecting data on SARS-CoV-2 for over a year to understand the complex, and frankly puzzling, disease profile. Doctors have not been able to explain why some people experience “long-COVID,” while other patients have minimal symptoms. A review in The Lancet Respiratory Medicine journal published earlier this month by a multidisciplinary group of European scientists sheds light on the biology behind this disease. 

The range of COVID-19 symptoms has been puzzling: multi-organ impacts, blood clots, and hyperactive immune responses. Animal and other experimental models suggest that the overly aggressive immune-inflammation response is to blame for the severe symptoms. However, data from human patients suggest that a dysregulated immune response is actually what leads to the range of severe symptoms.  

Ignacio Martin-Loeches, Clinical Professor in Trinity College Dublin's School of Medicine, Consultant in Intensive Care Medicine at St James's Hospital, and review co-author said, "Despite international focus on the virus, we are only just beginning to understand its intricacies. Based on growing evidence we propose that COVID-19 should be perceived as a new entity with a previously unknown infectious profile. It has its own characteristics and distinct pathophysiology and we need to be aware of this when treating people.”

"That doesn't mean we should abandon existing best-practice treatments that are based on our knowledge of other human coronaviruses, but an unbiased, gradual assembly of the key COVID-19 puzzle pieces for different patient cohorts - based on sex, age, ethnicity, pre-existing comorbidities - is what is need to modify the existing treatment guidelines, subsequently providing the most adequate care to COVID-19 patients."

The review article compiled the growing body of evidence indicating that the virus can infect both the upper and lower respiratory tracts. This is an important difference, since “weakly” pathogenic human coronavirus sub-species usually only affect the upper respiratory tract and cause mild symptoms, while “highly” pathogenic viruses such as SARS and ARDS settle in the lower respiratory tract. 

A table in the review clearly shows the known immune differences between SARS-CoV, MERS-CoV, and SARS-CoV-2 (COVID-19). Additionally, the scientists found that the association between viral load (the amount of virus particles in an infected person) and disease severity suggests that poor viral infection control by the immune system is a major contributor to severe COVID-19 cases. Further research is needed to complete the picture of the complex immune response profile in COVID-19 cases, as well as understand the duration of immunity in recovered patients. 

Sources: EurekAlert, The Lancet Respiratory Medicine

About the Author
  • Caroline Wallace has a PhD in Biomedical Science with over 15 peer-reviewed publications. Her scientific writing areas of interest include immunology, nutritional immunology, immuno-oncology, cancer prevention, and general wellness through natural products.
You May Also Like
AUG 17, 2021
Immunology
Does Fasting Help Protect Against Infection?
AUG 17, 2021
Does Fasting Help Protect Against Infection?
Most people feeling under the weather, especially those with a fever, tend to lose their appetites. When recovering from ...
AUG 27, 2021
Health & Medicine
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
AUG 27, 2021
Blood Group and COVID-19 Susceptibility- An Ongoing Debate
Since their discovery, there has been an interest in how ABO blood groups and infectious diseases may be related. In add ...
SEP 03, 2021
Cell & Molecular Biology
Is a Venom-Like Molecule Involved in COVID-19 Mortality?
SEP 03, 2021
Is a Venom-Like Molecule Involved in COVID-19 Mortality?
Scientists have sought to learn more about why some people get severe COVID-19 while others have only mild cases. We kno ...
SEP 23, 2021
Immunology
Enhanced Hamster Cells as Super Drug Factories
SEP 23, 2021
Enhanced Hamster Cells as Super Drug Factories
Antibodies are highly specialized proteins produced by the immune system that stick on to foreign invaders in the body w ...
OCT 12, 2021
Immunology
Major Landmark in a 100-Year Search for a Malaria Vaccine
OCT 12, 2021
Major Landmark in a 100-Year Search for a Malaria Vaccine
In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread d ...
NOV 08, 2021
Cell & Molecular Biology
Understanding How Problems in Bone Marrow Transplants Arise
NOV 08, 2021
Understanding How Problems in Bone Marrow Transplants Arise
The hematopoietic system is how new blood cells are formed; hematopoietic stem cells in bone marrow generate new hematop ...
Loading Comments...